Products for Research Use Only
RegisterLogin

CGP-35949 (sodium)

CAT: 0804-HY-19041Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-19041Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CGP-35949 sodium is a LTD4 antagonist with phospholipase inhibitory activity. CGP-35949 sodium can be used for research of asthma[1].
CAS Number
111130-13-3
UNSPSC
12352005
Target
Leukotriene Receptor; Phospholipase
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cgp-35949-sodium.html
Solubility
10 mM in DMSO
Smiles
ClC1=CC(C)=C(NC(C2=NN=N[N-]2)=O)C=C1OCCCOC3=CC=C(C(C)=O)C(O)=C3CCC.[Na+]
Molecular Formula
C23H25ClN5NaO5
Molecular Weight
509.92
References & Citations
[1]Beck A, et al. CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma. Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:771-4.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-19054-01CGP-20376
HY-121599-01CGP 36742
HY-111528CGP 43487
HY-100454-01CGP 25454A
HY-129563CGP 57813
HY-117559CGP-75355
HY-120192CGP 62349
HY-101837-01CGP 53716
HY-12405-01CGP-42112
HY-100329CGP 65015

Alternative Products

CatalogName
MBS5780453Cgp 35949
217271CGP 35348 (GABAB Receptor Antagonist, CGP 35348, CGP35348, CGP-35348)
B6602-10CGP 37157
B6655-5CGP 52432
B6654-50CGP 35348
B6751-50CGP 37849
B7384-5CGP 52411
NFA79473-01CGP 48664A
BC183635-01CGP 78608
MDA95867-01CGP 52608

Popular Products